These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Diagnostic standards for dopaminergic augmentation of restless legs syndrome: report from a World Association of Sleep Medicine-International Restless Legs Syndrome Study Group consensus conference at the Max Planck Institute. García-Borreguero D; Allen RP; Kohnen R; Högl B; Trenkwalder C; Oertel W; Hening WA; Paulus W; Rye D; Walters A; Winkelmann J; Earley CJ; Sleep Med; 2007 Aug; 8(5):520-30. PubMed ID: 17544323 [TBL] [Abstract][Full Text] [Related]
3. Restless legs syndrome in narcolepsy: a side effect of sodium oxybate? Abril B; Carlander B; Touchon J; Dauvilliers Y Sleep Med; 2007 Mar; 8(2):181-3. PubMed ID: 17275405 [TBL] [Abstract][Full Text] [Related]
4. Ropinirole in the treatment of restless legs syndrome. Kakar RS; Kushida CA Expert Rev Neurother; 2005 Jan; 5(1):35-42. PubMed ID: 15853472 [TBL] [Abstract][Full Text] [Related]
5. Too soon for dopaminergics in the management of restless legs syndrome in children. Harris MA Sleep Med Rev; 2009 Aug; 13(4):299-300; author reply 301-2. PubMed ID: 19477663 [No Abstract] [Full Text] [Related]
6. Changes of cortical excitability after dopaminergic treatment in restless legs syndrome. Scalise A; Pittaro-Cadore I; Janes F; Marinig R; Gigli GL Sleep Med; 2010 Jan; 11(1):75-81. PubMed ID: 19595629 [TBL] [Abstract][Full Text] [Related]
7. Dopamine dysregulation syndrome in a patient with restless legs syndrome. Leu-Semenescu S; Karroum E; Brion A; Konofal E; Arnulf I Sleep Med; 2009 Apr; 10(4):494-6. PubMed ID: 19410183 [TBL] [Abstract][Full Text] [Related]
11. State of the art in restless legs syndrome therapy: practice recommendations for treating restless legs syndrome. Oertel WH; Trenkwalder C; Zucconi M; Benes H; Borreguero DG; Bassetti C; Partinen M; Ferini-Strambi L; Stiasny-Kolster K Mov Disord; 2007; 22 Suppl 18():S466-75. PubMed ID: 17516455 [TBL] [Abstract][Full Text] [Related]
13. [Restless legs]. Kinge E; Lossius MI Tidsskr Nor Laegeforen; 2004 Jan; 124(1):25-7. PubMed ID: 14716387 [TBL] [Abstract][Full Text] [Related]
14. [Six months treatment of restless legs syndrome with levodopa/benserazide in domiciliary practice]. Mühlau G MMW Fortschr Med; 2004 Dec; 146(Suppl 3-4):87-93. PubMed ID: 15662897 [TBL] [Abstract][Full Text] [Related]
15. Restless Legs Syndrome After Single Low Dose Quetiapine Administration. Soyata AZ; Celebi F; Yargc LI Curr Drug Saf; 2016; 11(2):172-3. PubMed ID: 26582164 [TBL] [Abstract][Full Text] [Related]
16. Emerging drugs for restless legs syndrome. Fulda S; Wetter TC Expert Opin Emerg Drugs; 2005 Aug; 10(3):537-52. PubMed ID: 16083328 [TBL] [Abstract][Full Text] [Related]
17. Current guidelines and standards of practice for restless legs syndrome. Hening WA Am J Med; 2007 Jan; 120(1 Suppl 1):S22-7. PubMed ID: 17198767 [TBL] [Abstract][Full Text] [Related]
18. Does domperidone potentiate mirtazapine-associated restless legs syndrome? Chang CC; Shiah IS; Chang HA; Mao WC Prog Neuropsychopharmacol Biol Psychiatry; 2006 Mar; 30(2):316-8. PubMed ID: 16309808 [TBL] [Abstract][Full Text] [Related]
19. Restless legs syndrome--relevant aspects for internal medicine specialists. Sitaru C; Cristea V; Florea SM Rom J Intern Med; 1999; 37(3):275-86. PubMed ID: 15532306 [TBL] [Abstract][Full Text] [Related]
20. Nocturnal eating/drinking syndrome and neuroleptic-induced restless legs syndrome. Horiguchi J; Yamashita H; Mizuno S; Kuramoto Y; Kagaya A; Yamawaki S; Inami Y Int Clin Psychopharmacol; 1999 Jan; 14(1):33-6. PubMed ID: 10221640 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]